ScholarIQanswers from OpenAlex
Europeana Foundation
InstitutionResearch output, impact & collaborations
Europeana Foundation is a institution indexed in ScholarIQ from OpenAlex.
What is known about Europeana Foundation?
ScholarIQrecord summary
Europeana Foundation is a research organisation in The Hague, NL. OpenAlex records 260 works and 5,461 citations for it. 62 researchers list it as their most recent affiliation.
How many works does Europeana Foundation have?
ScholarIQindexed works
Europeana Foundation has 260 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Europeana Foundation have?
ScholarIQcitation count
Europeana Foundation has 5,461 citations in the OpenAlex counts ScholarIQ stores.
How many researchers are at Europeana Foundation?
ScholarIQresearcher count
Europeana Foundation has 62 researchers in the ScholarIQ index.
What is the average h-index at Europeana Foundation?
ScholarIQavg h-index
Europeana Foundation has an average h-index of 127 in OpenAlex.
What is the ROR of Europeana Foundation?
ScholarIQror
The ROR for Europeana Foundation is on the source record.
What is the OpenAlex record for Europeana Foundation?
ScholarIQopenalex
The OpenAlex for Europeana Foundation is on the source record.
Who are the most-cited researchers behind Europeana Foundation?
ScholarIQtop researchers by citations
What are the most-cited papers on Europeana Foundation?
ScholarIQmost cited works
Bortezomib, thalidomide, and dexamethasone with or without daratumumab before and after autologous stem-cell transplantation for newly diagnosed multiple myeloma (CASSIOPEIA): a randomised, open-label, phase 3 study
Philippe Moreau, Michel Attal, Cyrille Hulin, Bertrand Arnulf, Karim Belhadj, Lotfi Benboubker, Marie C. Béné, Annemiek Broijl, Hélène Caillon, Denis Caillot, Jill Corre, Michel Delforge, Thomas Dejoie, Chantal Doyen, Thierry Façon, Cécile Sonntag, Jean Fontan, Laurent Garderet, Kon‐Siong G. Jie, Lionel Karlin, Frédérique Kuhnowski, Jérôme Lambert, Xavier Leleu, Pascal Lenain, Margaret Macro, Claire Mathiot, Frédérique Orsini‐Piocelle, Aurore Perrot, Anne‐Marie Stoppa, Niels W.C.J. van de Donk, Soraya Wuillème, Sonja Zweegman, Brigitte Kolb, Cyrille Touzeau, Murielle Roussel, Mourad Tiab, Jean‐Pierre Marolleau, Nathalie Meuleman, Marie‐Christiane Vekemans, Matthijs Westerman, Saskia K. Klein, Mark‐David Levin, Jean Paul Fermand, Martine Escoffre‐Barbe, Jean‐Richard Eveillard, Réda Garidi, Tahamtan Ahmadi, Sen Hong Zhuang, Christopher Chiu, Lixia Pei, Carla de Boer, Elena Smith, William Deraedt, Tobias Kampfenkel, Jordan M. Schecter, Jessica Vermeulen, Hervé Avet‐Loiseau, Pieter Sonneveld
Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma
Pieter Sonneveld, Meletios Α. Dimopoulos, Mario Boccadoro, Hang Quach, P. Joy Ho, Meral Beksaç, Cyrille Hulin, Elisabetta Antonioli, Xavier Leleu, Silvia Mangiacavalli, Aurore Perrot, Michèle Cavo, Angelo Belotti, Annemiek Broijl, Francesca Gay, Roberto Mina, Inger S. Nijhof, Niels W.C.J. van de Donk, Eirini Katodritou, Fredrik Schjesvold, Anna Sureda, Laura Rosiñol, Michel Delforge, Wilfried Roeloffzen, Tobias Silzle, Annette Juul Vangsted, Hermann Einsele, Andrew Spencer, Roman Hájek, Artur Jurczyszyn, Sarah Lonergan, Tahamtan Ahmadi, Yanfang Liu, Jianping Wang, Diego Vieyra, Emilie M.J. van Brummelen, Véronique Vanquickelberghe, Anna Sitthi-Amorn, Carla J. de Boer, Robin Carson, Paula Rodríguez‐Otero, Joan Bladé, Philippe Moreau
LocoMMotion: a prospective, non-interventional, multinational study of real-life current standards of care in patients with relapsed and/or refractory multiple myeloma
María‐Victoria Mateos, Katja Weisel, Valerio De Stefano, Hartmut Goldschmidt, Michel Delforge, Mohamad Mohty, Michèle Cavo, Ravi Vij, Joanne Lindsey-Hill, Dominik Dytfeld, Emanuele Angelucci, Aurore Perrot, Reuben Benjamin, Niels W.C.J. van de Donk, Enrique M. Ocio, Christof Scheid, Francesca Gay, Wilfried Roeloffzen, Paula Rodríguez‐Otero, Annemiek Broijl, Anna Potamianou, Caline Sakabedoyan, Maria Semerjian, Sofia Keim, Vadim Strulev, Jordan M. Schecter, Martin Vogel, Robert Wapenaar, Tonia Nesheiwat, Jesús F. San Miguel, Pieter Sonneveld, Hermann Einsele, Philippe Moreau
Maintenance with daratumumab or observation following treatment with bortezomib, thalidomide, and dexamethasone with or without daratumumab and autologous stem-cell transplant in patients with newly diagnosed multiple myeloma (CASSIOPEIA): an open-label, randomised, phase 3 trial
Philippe Moreau, Cyrille Hulin, Aurore Perrot, Bertrand Arnulf, Karim Belhadj, Lotfi Benboubker, Marie C. Béné, Sonja Zweegman, Hélène Caillon, Denis Caillot, Jill Corre, Michel Delforge, Thomas Dejoie, Chantal Doyen, Thierry Façon, Cécile Sonntag, Jean Fontan, Mohamad Mohty, Kon‐Siong G. Jie, Lionel Karlin, Frédérique Kuhnowski, Jérôme Lambert, Xavier Leleu, Margaret Macro, Frédérique Orsini-Piocelle, Murielle Roussel, Anne‐Marie Stoppa, Niels W.C.J. van de Donk, Soraya Wuillème, Annemiek Broijl, Cyrille Touzeau, Mourad Tiab, Jean‐Pierre Marolleau, Nathalie Meuleman, Marie‐Christiane Vekemans, Matthijs Westerman, Saskia K. Klein, Mark‐David Levin, Fritz Offner, Martine Escoffre‐Barbe, Jean‐Richard Eveillard, Réda Garidi, Tahamtan Ahmadi, Maria Krevvata, Ke Zhang, Carla de Boer, Sanjay Vara, Tobias Kampfenkel, Véronique Vanquickelberghe, Jessica Vermeulen, Hervé Avet‐Loiseau, Pieter Sonneveld
International Myeloma Working Group guidelines for the management of multiple myeloma patients ineligible for standard high-dose chemotherapy with autologous stem cell transplantation
Antonio Palumbo, Orhan Sezer, Robert Kyle, Jesús F. San Miguel, Robert Z. Orlowski, Philippe Moreau, Rubén Niesvizky, Gareth J. Morgan, Raymond L. Comenzo, Pieter Sonneveld, Shaji Kumar, Roman Hájek, Sergio Giralt, Sara Bringhen, Kenneth Anderson, Paul G. Richardson, Michèle Cavo, Faith E. Davies, Joan Bladé, Hermann Einsele, Meletios Α. Dimopoulos, Andrew Spencer, Angela Dispenzieri, Tony Reiman, Kazuyuki Shimizu, J.H. Lee, Michel Attal, Mario Boccadoro, M.V. Mateos, Wei Chen, Heinz Ludwig, D. Joshua, Chor Sang Chim, Vânia Hungria, Ingemar Turesson, Brian Durie, Sagar Lonial, on behalf of the IMWG
How much of the research on Europeana Foundation is open access?
ScholarIQopen access share
80%OPEN ACCESS